Atai Life Sciences N.V.

BMV:ATAI N Stock Report

Market Cap: Mex$4.1b

Atai Life Sciences Future Growth

Future criteria checks 2/6

Atai Life Sciences is forecast to grow earnings and revenue by 35.4% and 77.5% per annum respectively. EPS is expected to grow by 49.6% per annum. Return on equity is forecast to be -50.8% in 3 years.

Key information

35.4%

Earnings growth rate

49.6%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate77.5%
Future return on equity-50.8%
Analyst coverage

Good

Last updated30 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:ATAI N - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202631-124-138-1326
12/31/20250-132-111-1206
12/31/20240-133-88-866
6/30/20240-58-79-79N/A
3/31/20240-34-86-86N/A
12/31/20230-40-85-84N/A
9/30/20230-67-93-93N/A
6/30/20230-145-104-102N/A
3/31/20230-149-103-102N/A
12/31/20220-152-105-104N/A
9/30/20220-196-97-94N/A
6/30/20221-194-96-95N/A
3/31/20220-205-73-71N/A
12/31/202120-168-65-63N/A
9/30/202120-166-50-49N/A
6/30/202120-218-27-26N/A
3/31/202120-185-34-33N/A
12/31/2020N/A-170-21-21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ATAI N is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ATAI N is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ATAI N is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ATAI N's revenue (77.5% per year) is forecast to grow faster than the MX market (7% per year).

High Growth Revenue: ATAI N's revenue (77.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ATAI N is forecast to be unprofitable in 3 years.


Discover growth companies